Corporate Profile

Webcast ImageWebcast
Teleflex Incorporated at UBS Global Healthcare Conference  (Replay)
05/22/17 at 11:00 a.m. ET
Teleflex Incorporated at UBS Global Healthcare Conference
Monday, May 22, 2017 11:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Teleflex Incorporated at Bank of America Merrill Lynch 2017 Health Care Conference  (Replay)
05/17/17 at 2:20 p.m. PT
Teleflex Incorporated at Bank of America Merrill Lynch 2017 Health Care Conference
Wednesday, May 17, 2017 2:20 p.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Q1 2017 Teleflex Incorporated Earnings Conference Call (Replay)
05/04/17 at 8:00 a.m. ET
Q1 2017 Teleflex Incorporated Earnings Conference Call
Thursday, May 4, 2017 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Teleflex is a global provider of medical technology products that enhance clinical benefits, improve patient and provider safety and reduce total procedural costs. To achieve this mission, Teleflex is committed to the following: investing in technology and developing our pipeline; leveraging and building our core franchises and distribution channels; attracting, developing and retaining talented employees around the world; and continuing to build financial strength by expanding our margins and maintaining strong cash flow all in an effort to successfully grow our reputation as a solid investment and a profitable, strong employer. We primarily design, develop, manufacture and supply single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. We sell our products to hospitals and healthcare providers worldwide through a combination of our direct sales force and distributors. Our products are used in a wide variety of markets and are not dependent upon any one end-market or procedure.

We are focused on achieving consistent , sustainable and profitable growth by increasing our market share and improving operating efficiencies through:

  • • the development of new products and product line extensions;

  • • the investment in new technologies and broadening their applications;

  • • the expansion of the use of existing products in existing markets, as well as in new geographic markets;

  • • leveraging our direct sales force and distribution network with new products, manufacturing and distribution facility rationalization and achieving economies of scale as we continue to expand; and

  • • the potential broadening of our product portfolio through select acquisitions, licensing arrangements and partnerships that enhance, extend or expedite our development initiatives or our ability to increase our market share.
 
Recent NewsMore »
05/15/17
Teleflex to Introduce the New Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump and the Product Portfolio from the Recently Acquired Vascular Solutions, Inc. at the European Association for Percutaneous Cardiovascular Interventions Course (EuroPCR)
WAYNE, Pa.--(BUSINESS WIRE)--May 15, 2017-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, will showcase its complex PCI product portfolio recently acquired from the purchase of Vascular Solutions and the new Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump (IABP) at the EuroPCR being held in Paris, France on May 16-19, 2017. With the recent acquisition of Vascular ... 
05/15/17
Teleflex (TFX) Announces Commencement of Phase I Clinical Study (FDP-1) of RePlas™ Freeze-Dried Plasma
The U.S. Army is sponsoring clinical trials of novel freeze-dried plasma developed by Teleflex’s Vascular Solutions division for the treatment of battlefield trauma and other emergency applications WAYNE, Pa.--(BUSINESS WIRE)--May 15, 2017-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced the commencement of the Phase I clinical study of RePlas, a lyophilized fre... 
05/08/17
Teleflex Quarterly Dividend – Correction of Record Date
WAYNE, Pa.--(BUSINESS WIRE)--May 8, 2017-- Teleflex Incorporated (NYSE: TFX) announced that the record date for its regular quarterly dividend announced earlier today is the close of business May 18, 2017, rather than May 15, 2017. The June 15, 2017 payment date remains the same. Additional information about Teleflex can be obtained from the company’s website at www.teleflex.com. About Teleflex Incorporated Teleflex is a global pro... 
05/08/17
Teleflex to Present at the 2017 UBS Global Healthcare Conference
WAYNE, Pa.--(BUSINESS WIRE)--May 8, 2017-- Liam Kelly, President and COO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 2017 UBS Global Healthcare Conference at the Grand Hyatt New York, New York, NY, on Monday, May 22, 2017 at 11:00 a.m. (ET). A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor portion of the Teleflex website at www.telefl... 
 
Upcoming EventsMore »
Teleflex Incorporated at UBS Global Healthcare Conference
Monday, May 22, 2017 11:00 a.m. ET
Supporting Materials
Download Event Supporting Material UBS Global Healthcare Conference Presentation
Add to Calendar Add Teleflex Incorporated at UBS Global Healthcare Conference  to Calendar  Help

 
Data provided by Nasdaq. Minimum 15 minutes delayed.


Print Page Print Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet